Identification of Fibroblast Growth Factor 9 (FGF9) as a High Affinity, Heparin Dependent Ligand for FGF Receptors 3 and 2 but not for FGF Receptors 1 and 4

References

• Aviezer D., Levy E., Safran M., Svahn C., Buddecke E., Schmidt A., David G., Vlodavsky I., Yayon A. Differential structural requirements of heparin and heparan sulfate proteoglycans that promote binding of basic fibroblast growth factor to its receptor. J. Biol. Chem. 1994; 269(1)114–121
   PubMedGoogle Scholar
• Baird A. Fibroblast growth factors: activities and significance of non-neurotrophin neurotrophic growth factors. Curr. Opin. Neurobiol. 1994; 4(1)78–86
   PubMedGoogle Scholar
• Basilico C., Moscatelli D. The FGF family of growth factors and oncogenes. Adv. Cancer Res. 1992; 159: 115–165
   Google Scholar
• Chellaiah A. T., McEwen D. G., Werner S., Xu J., Ornitz D. M. Fibroblast growth factor receptor 3. J. Biol. Chem. 1994; 269(15)11620–11622
   PubMedGoogle Scholar
• Cheon H. G., LaRochelle W. J., Bottaro D. P., Burgess W. H., Aaronson S. A. High-affinity binding sites for related fibroblast growth factor ligands reside within different receptor immunoglobulin-like domains. Proc. Natl Acad. Sci. USA 1994; 91(3)989–993
   PubMedGoogle Scholar
• Dionne C. A., Curmley G., Bellot F., Kaplow J. N., Scartoss G., Ruta M., Burgess D. H., Jaye M., Schlessinger J. Cloning and expression of two distinct high-affinity receptors cross reacting with acidic and basic fibroblast growth factors. EMBO J. 1990; 9: 2685–2692
   PubMed Web of Science ®Google Scholar
• Flanagan J. G., Chan D. C., Leder P. Transmembrane form of the kit ligand growth factor is determined by alternative splicing and is missing in the Sld mutant. Cell 1991; 64(5)1025–1035
   PubMedGoogle Scholar
• Flanagan J. G., Leder P. The kit Ligand: A cell surface molecule altered in Steel mutant fibroblasts. Cell 1990; 63: 185–194
   PubMed Web of Science ®Google Scholar
• Givol D., Yayon A. Complexity of FGF receptors: genetic basis for structural diversity and functional specificity. FASEB J. 1992; 6: 3362–3369
   PubMed Web of Science ®Google Scholar
• Hou J. Z., Kan M. K., McKeehan K., McBride G., Adams P., McKeehan W. L. Fibroblast growth factor receptors from liver vary in three structural domains. Science 1991; 251(4994)665–668
   PubMedGoogle Scholar
• Johnson D. E., Williams L. T. Structural and functional diversity in the FGF receptor multigene family. Adv. Cancer Res. 1993; 160: 1–41
   Google Scholar
• Kan M., Wang F., Xu J., Crabb J. W., Hou J., McKeehan W. L. An essential heparin-binding domain in the fibroblast growth factor receptor kinase. Science 1993; 259(5103)1918–21
   PubMed Web of Science ®Google Scholar
• Klagsbrun M. The fibroblast growth factor family: structural and biological properties. Progress in Growth Factor Research 1989; 1: 207–235
   PubMedGoogle Scholar
• Mansukhani A., Dell'Era P., Moscatelli D., Kornbluth S., Hanafusa H., Basilico C. Characterization of the murine BEK fibroblast growth factor (FGF) receptor: Activation by three members of the FGF family and requirement for heparin. Proc. Natl Acad. Sci. USA 1992; 89: 3305–3309
   PubMedGoogle Scholar
• McKeehan W. L., Kan M. Heparan sulfate fibroblast growth factor receptor complex: structure-function relationships. Mol. Reprod. Dev. 1994; 39(1)69–81
   PubMedGoogle Scholar
• Miki T., Bottaro D. P., Fleming T. P., Smith C. L., Burgess W. H., Chan A. M., Aaronson S. A. Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene. Proc. Natl Acad. Sci. USA 1992; 89: 246–250
   PubMed Web of Science ®Google Scholar
• Miki T., Fleming T. P., Bottaro D. P., Rubin J. S., Ron D., Aaronson S. A. Expression cDNA cloning of the KGF receptor by creation of a transforming autocrine loop. Science 1991; 251(4989)72–75
   PubMedGoogle Scholar
• Miyamoto M., Naruo K. -I., Matsumoto C. S., Kondo T. S., Kurokawa T. Molecular cloning of cytokine cDNA encoding the ninth member of the fibroblast growth family, which has a unique secretion property. Mol. Cell. Biol. 1993; 13(7)4251–4259
   PubMed Web of Science ®Google Scholar
• Moscatelli D. High and low affinity binding sites for basic fibroblast growth factor on cultured cells: absence of a role for low affinity binding in the stimulation of plasminogen activator production by bovine capillary endothelial cells. J. Cell. Physiol. 1987; 131: 123–130
   PubMed Web of Science ®Google Scholar
• Nauro K. -L., Seko C., Kuroshima K. -I., Matsutani E., Sasada R., Kondo T., Kurokawa T. Novel secretory heparin-binding factor from human glioma cells (glia activating factor) involved in glia cell growth. J. Biol. Chem. 1993; 268(4)2857–2864
   PubMedGoogle Scholar
• Ornitz D. M., Leder P. Ligand specificity and heparin dependence of fibroblast growth factor receptors 1 and 3. J. Biol. Chem. 1992; 267: 16305–16311
   PubMedGoogle Scholar
• Ornitz D. M., Yayon A., Flanagan J. G., Svahn C. M., Levi E., Leder P. Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells. Mol. Cell. Biol. 1991; 12: 240–247
   Google Scholar
• Peters K., Ornitz D., Werner S., Williams L. Unique expression pattern of the FGF receptor 3 gene during mouse organogenesis. Dev. Biol. 1993; 155(2)423–430
   PubMedGoogle Scholar
• Rapraeger A. C., Krufka A., Olwin B. B. Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science 1991; 252: 1705–1707
   PubMed Web of Science ®Google Scholar
• Rousseau F., Bonaventure J., Legeal-Mallet L., Pelet A., Rozet J. -M., Maroteaux P., Le-Merrer M., Munnich A. Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature 1994; 371: 252–254
   PubMed Web of Science ®Google Scholar
• Shiang R., Thompson L. M., Zhu Y. -Z., Church D. M., Winokur S. T., Wasmuth J. J. Mutations in trans-membrane domain of FGFR3 cause the most common genetic form of dwarfism, Achondroplasia. Cell 1994; 78: 335–342
   PubMed Web of Science ®Google Scholar
• Shing Y., Folkman J., Sullivan R., Butterfield C., Murray J., Klagsbrun M. Heparin affinity: purification of a tumor-derived capillary endothelial cell growth factor. Science 1984; 223(4642)1296–1299
   PubMed Web of Science ®Google Scholar
• Stanescu R., Stanescu V., Maroteaux P. Homozygous Achondroplasia: Morphologic and Biochemical Study of Cartilage. Am. J. Med. Genet. 1990; 37: 412–421
   PubMedGoogle Scholar
• Yayon A., Gray T. E., Zimmer Y., Eisenstein M., Givol D. Ligand binding by fibroblast growth factor receptors investigated using chimeric receptor molecules. J. of Receptor & Signal Transduction Research 1995; 15(1–4)185–197
   PubMed Web of Science ®Google Scholar
• Yayon A., Klagsbrun M., Esko J. D., Leder P., Ornitz D. M. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 1991; 64: 841–848
   PubMed Web of Science ®Google Scholar
• Yayon A., Zimmer Y., Guo-Hong S., Avivi A., Yarden Y., Givol D. A confined variable region confers ligand specificity on fibroblast growth factor receptors: implications for the origin of the immunoglobulin fold. EMBO J. 1992; 11(5)1885–1890
   PubMedGoogle Scholar
• Zimmer Y., Givol D., Yayon A. Multiple structural elements determine ligand binding of fibroblast growth factor receptors. J. Biol. Chem. 1993; 268: 7899–7903
   PubMedGoogle Scholar